Bora CDMO Bora CDMO

X

List of NDC API details of Regadenoson Active Pharmaceutical Ingredient listed on PharmaCompass.com

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Flag Czech Republic
Digital Content Digital Content
REGADENOSON MONOHYDRATE
POWDER (1kg/kg)
BULK INGREDIENT
63278-1068
2010-01-01
2024-12-31
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
Regadenoson Anhydrous
POWDER (100g/100g)
BULK INGREDIENT FOR ...
17180-0203
2008-04-10
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
Regadenoson
POWDER (10kg/10kg)
BULK INGREDIENT
62147-0220
2019-12-24
2024-12-31
Flag India
Digital Content Digital Content
URL Supplier Web Content
REGADENOSON
POWDER (1kg/kg)
BULK INGREDIENT
42973-229
2017-12-01
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
Regadenoson
POWDER (1kg/kg)
BULK INGREDIENT
69766-103
2021-11-24
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
Regadenoson
POWDER (1kg/kg)
BULK INGREDIENT
59285-029
2020-05-06
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Taiwan
Digital Content Digital Content
URL Supplier Web Content
Regadenoson
POWDER (1kg/kg)
BULK INGREDIENT
65129-1331
2015-01-01
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
REGADENOSON
POWDER (1kg/kg)
BULK INGREDIENT
76055-0024
2019-12-31
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Looking for 313348-27-5 / Regadenoson Monohydrate API manufacturers, exporters & distributors?

Regadenoson Monohydrate manufacturers, exporters & distributors 1

10

PharmaCompass offers a list of Regadenoson Monohydrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Regadenoson Monohydrate manufacturer or Regadenoson Monohydrate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Regadenoson Monohydrate manufacturer or Regadenoson Monohydrate supplier.

PharmaCompass also assists you with knowing the Regadenoson Monohydrate API Price utilized in the formulation of products. Regadenoson Monohydrate API Price is not always fixed or binding as the Regadenoson Monohydrate Price is obtained through a variety of data sources. The Regadenoson Monohydrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Regadenoson Monohydrate

Synonyms

313348-27-5, Lexiscan, Rapiscan, Cvt-3146, Regadenoson anhydrous, 2-[4-[(methylamino)carbonyl]-1h-pyrazol-1-yl]adenosine

Cas Number

313348-27-5

Unique Ingredient Identifier (UNII)

7AXV542LZ4

About Regadenoson Monohydrate

Regadenoson is an A2A adenosine receptor agonist that causes coronary vasodilation and used for myocardial perfusion imagining. Manufactured by Astellas and FDA approved April 10, 2008.

Regadenoson Manufacturers

A Regadenoson manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Regadenoson, including repackagers and relabelers. The FDA regulates Regadenoson manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Regadenoson API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Regadenoson manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Regadenoson Suppliers

A Regadenoson supplier is an individual or a company that provides Regadenoson active pharmaceutical ingredient (API) or Regadenoson finished formulations upon request. The Regadenoson suppliers may include Regadenoson API manufacturers, exporters, distributors and traders.

click here to find a list of Regadenoson suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Regadenoson NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Regadenoson as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Regadenoson API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Regadenoson as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Regadenoson and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Regadenoson NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Regadenoson suppliers with NDC on PharmaCompass.

Regadenoson Manufacturers | Traders | Suppliers

Regadenoson Manufacturers, Traders, Suppliers 1
57

We have 8 companies offering Regadenoson

Get in contact with the supplier of your choice:

  1. FARMAK, a.s
  2. Curia
  3. USV Private Limited
  4. Apicore LLC
  5. MSN Laboratories
  6. Optimus Pharma
  7. ScinoPharm Taiwan, Ltd
  8. Sionc Pharmaceuticals
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY